Talking about what others are afraid to say
Drug companies have poured billions of dollars into precision medicine research and development. They’re discovering mutations that help us treat cancers more precisely and creating therapies that target specific patient …
Cancer doesn’t pause while the paperwork’s in progress. Read More
The report’s central message is that healthcare professionals still have substantial influence, but they no longer have a monopoly on health authority. Patients operate in an information environment filled with family, …
Key points from the 2026 Edelman/Yale health trust analysis Read More
A new study published this week in JAMA is forcing a tough conversation about the latest wave of weight-loss drugs: what happens when you stop taking them? The research looked …
Long-Term Use of Tirzepatide Might Be Necessary Read More
In the U.S., we accept the logic of insurance in nearly every aspect of our lives — except, somehow, where it matters most: health. America has almost 150 million homes. …
Trump’s consumer-driven healthcare is an irresponsibly destructive idea Read More
AbbVie announced it has settled litigation with generic manufacturers in a way that effectively keeps competition for its blockbuster immunology drug Rinvoq off the market until 2037. Let that sink in: …
Why AbbVie’s Legal Strategy is Bad for Patients Read More
DSM-IV-TR to the DSM-5. The DSM-5, published by the American Psychiatric Association, consolidated the previously separate diagnoses of Autistic Disorder, Asperger’s Disorder, and Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) into …
How Have The Criteria for Diagnosing Autism Changed? Read More
The role of Pharmacy Benefit Managers (PBMs) in the healthcare system has long been debated and scrutinized. Recently, PBMs have been under fire for their opaque pricing practices, which often …
Are Pharmacy Benefit Managers Harming Patients? Key Insights Read More
Obtaining insurance coverage for the off-label use of oncology drugs can be challenging due to several factors. Off-label use refers to prescribing a drug for an indication not approved by the …
Key Factors for Securing Off-Label Oncology Drug Reimbursement Read More